|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
1 Department of Anatomy, School of Medicine, National Yang-Ming University, Taipei, Taiwan
2 Institute of Anatomy and Cell Biology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
3 Institute of Physiology and Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Research and Education, Veterans General Hospital, Taipei, Taiwan
4 Center for Neural Regeneration, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan; Neural Regeneration Laboratory, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
5 Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, School of Medicine, Taipei Medical University, Taipei, Taiwan
6 Department of Anatomy, China Medical University, Taichung, Taiwan
7 Institute of Medical Science, China Medical University, Taichung, Taiwan
* To whom correspondence should be addressed. E-mail: ysfu{at}ym.edu.tw.
| Abstract |
|---|
Human mesenchymal stem cells isolated from Wharton's jelly of the umbilical cord were induced to transform into dopaminergic neurons in vitro through stepwise culturing in neuron condition medium (NCM), SHH, and FGF8. The success rate was 12.7% as characterized by positive staining for tyrosine hydroxylase (TH), the rate limiting catecholaminergic synthesizing enzyme and dopamine being released into the culture medium. Transplantation of such cells into the striatum of rats previously made Parkinsonian by unilateral striatal lesioning with the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) partially corrected the lesion-induced amphetamine-evoked rotation. Viability of the transplanted cells, at least 4 months after transplantation, was identified by positive TH staining and migration of 1.4 mm both rostrally and caudaully. The results suggest that human umbilical mesenchymal stem cells have the potential for treatment of Parkinson's disease.
Key Words. Human umbilical mesenchymal stem cells, Parkinson's disease, Transplantation, Dopaminergic neuron, Tyrosine Hydroxylase
This article has been cited by other articles:
![]() |
D. L. Troyer and M. L. Weiss Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell Population Stem Cells, March 1, 2008; 26(3): 591 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Secco, E. Zucconi, N. M. Vieira, L. L.Q. Fogaca, A. Cerqueira, M. D. F. Carvalho, T. Jazedje, O. K. Okamoto, A. R. Muotri, and M. Zatz Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood! Stem Cells, January 1, 2008; 26(1): 146 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Trzaska, E. V. Kuzhikandathil, and P. Rameshwar Specification of a Dopaminergic Phenotype from Adult Human Mesenchymal Stem Cells Stem Cells, November 1, 2007; 25(11): 2797 - 2808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Can and S. Karahuseyinoglu Concise Review: Human Umbilical Cord Stroma with Regard to the Source of Fetus-Derived Stem Cells Stem Cells, November 1, 2007; 25(11): 2886 - 2895. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Phinney and D. J. Prockop Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair Current Views Stem Cells, November 1, 2007; 25(11): 2896 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Tsai, S.-M. Hwang, K.-D. Chen, Y.-S. Lee, L.-W. Hsu, Y.-J. Chang, C.-N. Wang, H.-H. Peng, Y.-L. Chang, A.-S. Chao, et al. Functional Network Analysis of the Transcriptomes of Mesenchymal Stem Cells Derived from Amniotic Fluid, Amniotic Membrane, Cord Blood, and Bone Marrow Stem Cells, October 1, 2007; 25(10): 2511 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Park, K. H. Jung, S. H. Kim, K. S. Kim, M. R. Choi, Y. Kim, and Y. G. Chai Functional Expression of Ion Channels in Mesenchymal Stem Cells Derived from Umbilical Cord Vein Stem Cells, August 1, 2007; 25(8): 2044 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baksh, R. Yao, and R. S. Tuan Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow Stem Cells, June 1, 2007; 25(6): 1384 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karahuseyinoglu, O. Cinar, E. Kilic, F. Kara, G. G. Akay, D. O. Demiralp, A. Tukun, D. Uckan, and A. Can Biology of Stem Cells in Human Umbilical Cord Stroma: In Situ and In Vitro Surveys Stem Cells, February 1, 2007; 25(2): 319 - 331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
